세계의 HERG 스크리닝 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 12.0%, 29억 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 맞춤형 의료의 확대, 의약품 개발 활동의 아웃소싱 증가, 신흥국 시장 및 연구, 비심장 안전성 평가에 대한 주력 등에 기인하는 것으로 예상됩니다. 예측 기간의 주요 동향은 고급 생체 외 모델, 유전체 및 단백질체학 데이터 통합, 컴퓨팅 접근법의 발전, 소아의 의약품 안전성에 대한 주목, 데이터 공유 및 표준화를 위한 공동 연구 등을 포함합니다.
심장 질환 환자 증가는 향후 수년간 HERG 스크리닝 시장의 확대를 촉진할 것으로 예상됩니다. 심장 질환은 심혈관 질환이라고도 불리며 심장과 혈관에 영향을 미치는 다양한 질병을 포함합니다. 이러한 문제는 심장 기능을 손상시키고 심각한 건강 합병증을 유발할 수 있습니다. 이러한 질병의 요인으로는 건강에 해로운 라이프 스타일, 노화, 유전 적 소인, 당뇨병, 대사 증후군 등이 있습니다. HERG 스크리닝은 잠재적인 약물 후보를 확인하고 생명을 위협하는 부정맥, 특히 TdP(Torsade de Pointes)와 같은 심장 부작용의 위험을 줄이고 환자의 결과를 향상시키는 데 중요한 역할을 합니다. 예를 들어 2023년 5월 미국 질병예방관리센터(CDC)가 발표한 보고서에 따르면 미국에서는 20세 이상의 성인 20명 중 1명이 심혈관 질환을 앓고 있으며, 이러한 질환으로 인해 695,000명이 이환되어 375,476명이 사망한 것으로 나타났습니다. 마찬가지로, 2022년 3월에 발표된 영국 국가 통계국의 데이터에 따르면, 심장 발작으로 사망한 사람은 20,061명으로 전년보다 증가하고 있습니다. 따라서 심장 질환의 유병률 증가는 HERG 스크리닝 시장의 확대에 기여합니다.
HERG 스크리닝 시장의 주요 기업은 의약품 개발 과정에서 심장 안전성 평가를 강화하기 위해 GLP 인증 HERG 스크리닝 서비스와 같은 혁신적인 솔루션에 적극적으로 주력하고 있습니다. S7B와 같은 규제 지침을 준수하는 전통적인 전체 세포 패치 클램프 방법을 사용하여 인간 에테르 a-go-go 관련 유전자(hERG)를 스크리닝합니다. 2023년 8월, Metrion Biosciences Ltd.는 GLP 인증 HERG 스크리닝 서비스를 도입했습니다. 이 서비스는 저분자 치료제 개발을 지원하고 기존의 심장 안전 서비스 포트폴리오를 보완하도록 설계되어, 제1상 임상시험에 들어가기 전에 전통적인 전체 세포 패치 클램프 방법을 사용하여 잠재적인 심장 부채를 평가합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 HERG 스크리닝 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 HERG 스크리닝 시장 : 성장률 분석
- 세계의 HERG 스크리닝 시장 실적 : 규모와 성장, 2019-2024
- 세계의 HERG 스크리닝 시장 예측 : 규모와 성장, 2024-2029년, 2034F
- 세계의 HERG 스크리닝 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 HERG 스크리닝 시장 : 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 유전자 KCNH2
- 돌연변이 KCNH2
- 세계의 HERG 스크리닝 시장 : 이온 채널별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 전압 게이트
- 리간드 게이트
- 세계의 HERG 스크리닝 시장 : 용도별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 항부정맥제
- 항정신병약
- 항생제
- 기타 용도
- 세계의 HERG 스크리닝 시장 : 유전자 KCNH2별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 야생형 KCNH2
- 재조합 KCNH2
- 세계의 HERG 스크리닝 시장 : 변이 KCNH2별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 돌연변이
- 미스센스 변이
- 넌센스 돌연변이
- 프레임 시프트 돌연변이
제7장 지역별 및 국가별 분석
- 세계의 HERG 스크리닝 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 세계의 HERG 스크리닝 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- HERG 스크리닝 시장 : 경쟁 구도
- HERG 스크리닝 시장 : 기업 프로파일
- Eurofins-Cerep SA. : 개요, 상품 및 서비스, 전략 및 재무분석
- Aviva Biosciences Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
- AstraZeneca Public Limited Company : 개요, 상품 및 서비스, 전략 및 재무분석
- Merck KGaA : 개요, 상품 및 서비스, 전략 및 재무분석
- Charles River Laboratories Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
제31장 기타 주요 기업 및 혁신 기업
- Abcam Public Limited Company
- Molecular Devices LLC
- Caliper Life Sciences Inc.
- Crprotex Limited
- ChanTest Corporation
- Creative bioarray Inc.
- Cellular Dynamics International Inc.
- Nanion Technologies
- Essen Bioscience
- ABR-Affinity BioReagents Inc.
- ACEA Biosciences Inc.
- Metrion biosciences Inc.
- Aurora Biomed Inc.
- Aureus Sciences
- RedShift BioAnalytics
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- HERG 스크리닝 시장(2029년) : 새로운 기회를 제공하는 국가
- HERG 스크리닝 시장(2029년) : 새로운 기회를 제공하는 부문
- HERG 스크리닝 시장(2029년) : 성장 전략
제36장 부록
JHS
Human Ether-a-go-go-related gene (HERG) screening is a crucial step in evaluating the potential cardiotoxic effects of a drug or compound. This screening process plays a vital role in preclinical safety assessment within the drug discovery and development phases, serving to guarantee the safety and effectiveness of newly developed therapeutic agents.
HERG screening encompasses two primary categories, gene KCNH2 and mutant KCNH2. The KCNH2 gene, also recognized as the human ether-a-go-go-related gene (hERG) or hERG gene, encodes the alpha subunit of a potassium ion channel pivotal in the regulation of the heart's electrical activity. This gene encompasses diverse ion channels, including both voltage-gated and ligand-gated variations. Its applications span across various therapeutic domains, including antiarrhythmics, antipsychotics, antibiotics, and others, underscoring its critical role in multiple medical contexts.
The HERG screening market research report is one of a series of new reports from The Business Research Company that provides HERG screening market statistics, including HERG screening industry global market size, regional shares, competitors with a HERG screening market share, detailed HERG screening market segments, market trends and opportunities, and any further data you may need to thrive in the HERG screening industry. This HERG screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The HERG screening market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.84 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to increasing drug development activities, regulatory requirements, increasing awareness of cardiac safety, rising incidence of cardiac disorders.
The HERG screening market size is expected to see rapid growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to expansion of personalized medicine, increasing outsourcing of drug development activities, emerging markets and research, focus on non-cardiac safety assessments. Major trends in the forecast period include advanced in vitro models, integration of genomic and proteomic data, advancements in computational approaches, focus on pediatric drug safety, collaborations for data sharing and standardization.
The increasing number of patients with heart disorders is expected to drive the expansion of the HERG screening market in the coming years. Heart disorders, also referred to as cardiovascular diseases, encompass a range of conditions affecting the heart and blood vessels. These issues can impair the heart's functionality and may result in serious health complications. Factors contributing to these disorders include unhealthy lifestyles, aging populations, genetic predispositions, diabetes, and metabolic syndrome. HERG screening plays a critical role in identifying potential drug candidates, reducing the risk of adverse cardiac events like life-threatening arrhythmias, particularly torsade de pointes (TdP), and enhancing patient outcomes. For example, a report by the Centers for Disease Control and Prevention (CDC) in May 2023 revealed that 1 in 20 adults aged 20 and above in the United States have cardiovascular diseases, with 695,000 people affected and 375,476 deaths due to these conditions. Similarly, data from the Office for National Statistics in the UK, published in March 2022, indicated that 20,061 people died of heart attacks, an increase from the previous year. Thus, the growing prevalence of heart disorders is contributing to the expanding HERG screening market.
Key companies in the HERG screening market are actively focusing on innovative solutions, including GLP-certified HERG screening services, to enhance cardiac safety assessments during drug development processes. GLP-certified HERG screening involves screening the human ether-a-go-go related gene (hERG) using the conventional whole-cell patch-clamp technique, ensuring compliance with regulatory guidelines such as ICH S7A and ICH S7B. These guidelines are critical for safety pharmacology studies in drug development. For example, in August 2023, Metrion Biosciences Ltd., a UK-based pharmaceutical company, introduced the GLP-certified hERG screening service. This service is designed to support small-molecule therapeutic development, complement the existing cardiac safety service portfolio, and employ the conventional whole-cell patch-clamp technique to assess potential cardiac liabilities before entering Phase 1 clinical trials. It provides regulatory guidance for safety pharmacology studies and offers high-quality biology services for ion channel targets.
In January 2022, the Tox21 research program was established through a partnership among several US-based agencies, including the National Toxicology Program, the Environmental Protection Agency, the National Center for Advancing Translational Science, and the Food and Drug Administration. This collaboration aims to enhance the methods used for chemical toxicity testing. The agencies work together to rapidly and efficiently assess the safety of various chemicals, including those found in everyday products. Specifically for HERG screening, their objective is to analyze the molecular mechanisms of these chemicals, prioritize those requiring further investigation, and develop predictive models to evaluate their effects on living organisms.
Major companies operating in the HERG screening market are Eurofins-Cerep SA., Aviva Biosciences Inc., AstraZeneca Public Limited Company, Merck KGaA, Charles River Laboratories Inc., Abcam Public Limited Company, Molecular Devices LLC, Caliper Life Sciences Inc., Crprotex Limited, ChanTest Corporation, Creative bioarray Inc., Cellular Dynamics International Inc., Nanion Technologies, Essen Bioscience, ABR-Affinity BioReagents Inc., ACEA Biosciences Inc., Metrion biosciences Inc., Aurora Biomed Inc., Aureus Sciences, RedShift BioAnalytics, B'SYS GmbH, Cambridge Bioscience Ltd., Sophion Bioscience Inc., Fluxion Biosciences Inc., ChemAxon Ltd.
North America was the largest region in the HERG screening market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the herg screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the herg screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The HERG screening market includes revenues earned by entities by providing services such as in vitro HERG assays, patch clamp electrophysiology, data analysis and interpretation, consultation and regulatory support, and customized assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
HERG Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on herg screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for herg screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The herg screening market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Gene KCNH2; Mutant KCNH2
- 2) By Ion Channel: Voltage-Gated; Ligand Gated
- 3) By Applications: Antiarrhythmic; Antipsychotic; Antibiotics; Other Applications
- Subsegmeents:
- 1) By Gene KCNH2: Wild-Type KCNH2; Recombinant KCNH2
- 2) By Mutant KCNH2: Mutations: Missense Mutations; Nonsense Mutations; Frameshift Mutations
- Companies Mentioned: Eurofins-Cerep SA.; Aviva Biosciences Inc.; AstraZeneca Public Limited Company; Merck KGaA; Charles River Laboratories Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. HERG Screening Market Characteristics
3. HERG Screening Market Trends And Strategies
4. HERG Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global HERG Screening Growth Analysis And Strategic Analysis Framework
- 5.1. Global HERG Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global HERG Screening Market Growth Rate Analysis
- 5.4. Global HERG Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global HERG Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global HERG Screening Total Addressable Market (TAM)
6. HERG Screening Market Segmentation
- 6.1. Global HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gene KCNH2
- Mutant KCNH2
- 6.2. Global HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Voltage-Gated
- Ligand Gated
- 6.3. Global HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antiarrhythmic
- Antipsychotic
- Antibiotics
- Other Applications
- 6.4. Global HERG Screening Market, Sub-Segmentation Of Gene KCNH2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Wild-Type KCNH2
- Recombinant KCNH2
- 6.5. Global HERG Screening Market, Sub-Segmentation Of Mutant KCNH2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mutations
- Missense Mutations
- Nonsense Mutations
- Frameshift Mutations
7. HERG Screening Market Regional And Country Analysis
- 7.1. Global HERG Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global HERG Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific HERG Screening Market
- 8.1. Asia-Pacific HERG Screening Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China HERG Screening Market
- 9.1. China HERG Screening Market Overview
- 9.2. China HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India HERG Screening Market
- 10.1. India HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan HERG Screening Market
- 11.1. Japan HERG Screening Market Overview
- 11.2. Japan HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia HERG Screening Market
- 12.1. Australia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia HERG Screening Market
- 13.1. Indonesia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea HERG Screening Market
- 14.1. South Korea HERG Screening Market Overview
- 14.2. South Korea HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe HERG Screening Market
- 15.1. Western Europe HERG Screening Market Overview
- 15.2. Western Europe HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK HERG Screening Market
- 16.1. UK HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany HERG Screening Market
- 17.1. Germany HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France HERG Screening Market
- 18.1. France HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy HERG Screening Market
- 19.1. Italy HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain HERG Screening Market
- 20.1. Spain HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe HERG Screening Market
- 21.1. Eastern Europe HERG Screening Market Overview
- 21.2. Eastern Europe HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia HERG Screening Market
- 22.1. Russia HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America HERG Screening Market
- 23.1. North America HERG Screening Market Overview
- 23.2. North America HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA HERG Screening Market
- 24.1. USA HERG Screening Market Overview
- 24.2. USA HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada HERG Screening Market
- 25.1. Canada HERG Screening Market Overview
- 25.2. Canada HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America HERG Screening Market
- 26.1. South America HERG Screening Market Overview
- 26.2. South America HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil HERG Screening Market
- 27.1. Brazil HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East HERG Screening Market
- 28.1. Middle East HERG Screening Market Overview
- 28.2. Middle East HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa HERG Screening Market
- 29.1. Africa HERG Screening Market Overview
- 29.2. Africa HERG Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa HERG Screening Market, Segmentation By Ion Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa HERG Screening Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. HERG Screening Market Competitive Landscape And Company Profiles
- 30.1. HERG Screening Market Competitive Landscape
- 30.2. HERG Screening Market Company Profiles
- 30.2.1. Eurofins-Cerep SA. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Aviva Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AstraZeneca Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
31. HERG Screening Market Other Major And Innovative Companies
- 31.1. Abcam Public Limited Company
- 31.2. Molecular Devices LLC
- 31.3. Caliper Life Sciences Inc.
- 31.4. Crprotex Limited
- 31.5. ChanTest Corporation
- 31.6. Creative bioarray Inc.
- 31.7. Cellular Dynamics International Inc.
- 31.8. Nanion Technologies
- 31.9. Essen Bioscience
- 31.10. ABR-Affinity BioReagents Inc.
- 31.11. ACEA Biosciences Inc.
- 31.12. Metrion biosciences Inc.
- 31.13. Aurora Biomed Inc.
- 31.14. Aureus Sciences
- 31.15. RedShift BioAnalytics
32. Global HERG Screening Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The HERG Screening Market
34. Recent Developments In The HERG Screening Market
35. HERG Screening Market High Potential Countries, Segments and Strategies
- 35.1 HERG Screening Market In 2029 - Countries Offering Most New Opportunities
- 35.2 HERG Screening Market In 2029 - Segments Offering Most New Opportunities
- 35.3 HERG Screening Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
